ARTICLE | Company News
J&J, Valneva deal
February 16, 2015 8:00 AM UTC
Valneva purchased Crucell Sweden AB from Johnson & Johnson’s Janssen’s Crucell Holland B.V. for EUR45 million ($51 million). The deal includes the vaccine Dukoral, which prevents cholera and traveler...